Concepedia

Treatment of Vascular Rejection With Rituximab in Cardiac Transplantation

H. Edward Garrett, Denise Duvall-Seaman, Beth Helsley, Kenneth Groshart

The Journal of Heart and Lung Transplantation · 2005 · 82 citations · 20 references

DOI

Concepts

References

20

Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients

Nöel Milpied, B. Vasseur, Nathalie Parquet et al. · Annals of Oncology · 2000 · 376 citations · Full text

, , +16

Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications.

Elizabeth H. Hammond, Robert L. Yowell, Shinichi Nunoda et al. · PubMed · 1990 · 321 citations

, , +14

Rituximab as Treatment for Refractory Kidney Transplant Rejection

Yolanda T. Becker, Bryan N. Becker, John D. Pirsch et al. · American Journal of Transplantation · 2004 · 308 citations

, , +12

Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs.

Steve Alas, Benjamin Bonavida · PubMed · 2001 · 295 citations

, , +17

Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma.

A.J. Grillo-López, Christine A. White, C. Varns et al. · PubMed · 1999 · 294 citations

, , +14